1
|
Memon S, Lal S, Thomas J. Navigating the Maze - A Unique Case of Intestinal Obstruction in Late Pregnancy. Ir Med J 2024; 117:951. [PMID: 38683116] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/01/2024]
|
2
|
Kumar M, Lal S, Khan E. Managing Post Operative Nausea and Vomiting and Perineal Itching A Slow and Steady Solution. Ir Med J 2023; 116:822. [PMID: 37606540] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 08/23/2023]
|
3
|
Silva JV, Sueyoshi S, Snape TJ, Lal S, Giarolla J. Pteridine reductase (PTR1): initial structure-activity relationships studies of potential leishmanicidal arylindole derivatives compounds. SAR QSAR Environ Res 2023; 34:661-687. [PMID: 37606690 DOI: 10.1080/1062936x.2023.2247331] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/07/2023] [Accepted: 07/08/2023] [Indexed: 08/23/2023]
Abstract
Leishmaniasis is a public health concern, especially in Brazil and India. The drugs available for therapy are old, cause toxicity and have reports of resistance. Therefore, this paper aimed to carry out initial structure-activity relationships (applying molecular docking and dynamic simulations) of arylindole scaffolds against the pteridine reductase (PTR1), which is essential target for the survival of the parasite. Thus, we used a series of 43 arylindole derivatives as a privileged skeleton, which have been evaluated previously for different biological actions. Compound 7 stood out among its analogues presenting the best results of average number of interactions with binding site (2.00) and catalytic triad (1.00). Additionally, the same compound presented the best binding free energy (-32.33 kcal/mol) in dynamic simulations. Furthermore, with computational studies, it was possible to comprehend and discuss the influences of the substituent sizes, positions of substitutions in the aromatic ring and electronic influences. Therefore, this study can be a starting point for the structural improvements needed to obtain a good leishmanicidal drug.
Collapse
Affiliation(s)
- J V Silva
- Department of Pharmacy, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil
| | - S Sueyoshi
- Department of Pharmacy, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil
| | - T J Snape
- Leicester School of Pharmacy, De Montfort University, Leicester, UK
| | - S Lal
- Amity Institute of Pharmacy, Amity University, Gurugram, India
| | - J Giarolla
- Department of Pharmacy, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil
| |
Collapse
|
4
|
Kumar M, Lal S, Memon Z. The Potential of Accuro Technology for Epidural and Spinal Anaesthesia in Irish Hospital Settings. Ir Med J 2023; 116:797. [PMID: 37555498] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 08/10/2023]
|
5
|
Kumar M, Lal S, Thomas J. Challenges and Considerations in Anaesthetic Management of Patients with Past Double Lung Transplant for Non-pulmonary Surgeries. Ir Med J 2023; 116:796. [PMID: 37555497] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 08/10/2023]
|
6
|
Lal S, Shafique Tahir M, Abdal M, Larkin C. Care not documented is care not given - Devising the intubation procedure documentation tool. Ir Med J 2023; 116:766. [PMID: 37555582] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 08/10/2023]
|
7
|
Deutsch L, Cloutier A, Leahy G, Teubner A, Abraham A, Taylor M, Paine P, Lal S. Factors Associated With Strong Opioid Use For Non-Cancer Pain In Patients With Chronic Intestinal Failure. Clin Nutr ESPEN 2023. [DOI: 10.1016/j.clnesp.2022.09.289] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/28/2023]
|
8
|
Joly F, Nuzzo A, Cuerda C, Jeppesen P, Lal S, Lamprecht G, Manpreet M, Szczepanek K, Van Gossum A, Wanten G, Pironi L. A Multi-National Survey Of Experience And Attitudes Towards Managing Catheter Related Blood Stream Infection During Hpn. Clin Nutr ESPEN 2023. [DOI: 10.1016/j.clnesp.2022.09.272] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/28/2023]
|
9
|
Thomas J, Lal S, Chua ZH. Sphenopalatine Ganglion Block (SPGB) and Greater Occipital Nerve Block. Ir Med J 2023; 116:738. [PMID: 37555806] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 08/10/2023]
|
10
|
Kumar P, Singh R, Kumar A, Toropova AP, Toropov AA, Devi M, Lal S, Sindhu J, Singh D. Identifications of good and bad structural fragments of hydrazone/2,5-disubstituted-1,3,4-oxadiazole hybrids with correlation intensity index and consensus modelling using Monte Carlo based QSAR studies, their molecular docking and ADME analysis. SAR QSAR Environ Res 2022; 33:677-700. [PMID: 36093620 DOI: 10.1080/1062936x.2022.2120068] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/14/2022] [Accepted: 08/25/2022] [Indexed: 06/15/2023]
Abstract
The application of QSAR along with other in silico tools like molecular docking, and molecular dynamics provide a lot of promise for finding new treatments for life-threatening diseases like Type 2 diabetes mellitus (T2DM). The present study is an attempt to develop Monte Carlo algorithm-based QSAR models using freely available CORAL software. The experimental data on the α-amylase inhibition by a series of benzothiazole-linked hydrazone/2,5-disubstituted-1,3,4-oxadiazole hybrids were selected as endpoint for the model generation. Initially, a total of eight QSAR models were built using correlation intensity index (CII) as a criterion of predictive potential. The model developed from split 6 using CII was the most reliable because of the highest numerical value of the determination coefficient of the validation set (r2VAL = 0.8739). The important structural fragments responsible for altering the endpoint were also extracted from the best-built model. With the goal of improved prediction quality and lower prediction errors, the validated models were used to build consensus models. Molecular docking was used to know the binding mode and pose of the selected derivatives. Further, to get insight into their metabolism by living beings, ADME studies were investigated using internet freeware, SwissADME.
Collapse
Affiliation(s)
- P Kumar
- Department of Chemistry, Kurukshetra University, Kurukshetra, India
| | - R Singh
- Department of Chemistry, Kurukshetra University, Kurukshetra, India
| | - A Kumar
- Department of Pharmaceutical Sciences, GJUS&T, Hisar, India
| | - A P Toropova
- Department of Environmental Health Science, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy
| | - A A Toropov
- Department of Environmental Health Science, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy
| | - M Devi
- Department of Chemistry, Kurukshetra University, Kurukshetra, India
| | - S Lal
- Department of Chemistry, Kurukshetra University, Kurukshetra, India
| | - J Sindhu
- Department of Chemistry, COBS&H, CCS Haryana Agricultural University, Hisar, India
| | - D Singh
- Department of Chemistry, Maharshi Dayanand University, Rohtak, India
| |
Collapse
|
11
|
Wight R, Murphy A, Bower J, Morgan R, Flanagan L, Maycock S, Lal S, Teubner A, Abraham A, Mitchell C, Hasan J, Jayson G, Clamp A, Salih Z. 43P Malignant bowel obstruction in advanced ovarian cancer: A retrospective analysis of patients supported with parenteral nutrition. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.04.061] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
12
|
Kopczynska M, Teubner A, Taylor M, Abraham A, Hvas C, Burden S, Carlson G, Lal S. Nutritional autonomy in Short Bowel Syndrome and Intestinal Fistulas. Clin Nutr ESPEN 2022. [DOI: 10.1016/j.clnesp.2022.02.045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
13
|
Naghibi M, Skinner C, Burden S, Bozzetti F, Cuerda C, Joly F, Jeppesen P, Lamprecht G, Mundi M, Szczepanek K, Van Gossum A, Wanten G, Pironi L, Lal S. A multi-national survey of experience and attitudes towards commencing home parenteral nutrition for patients with advanced cancer. Clin Nutr ESPEN 2022; 47:246-251. [DOI: 10.1016/j.clnesp.2021.12.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2021] [Accepted: 12/01/2021] [Indexed: 01/16/2023]
|
14
|
Wu T, Mark D, Howpage S, Lal S, Twigg S, Puranik R, Omran Y. CMR Evaluation of Aortic Distensibility in Well=Controlled Diabetic Patients. Heart Lung Circ 2022. [DOI: 10.1016/j.hlc.2022.06.235] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
15
|
Liu R, Koay Y, Kaye D, O’Sullivan J, Lal S. Male and Female Heart Failure With Preserved Ejection Fraction (HFpEF): An Insight Into the Differential Metabolic, Hypertensive, Exercise and Ketone Parameters. Heart Lung Circ 2022. [DOI: 10.1016/j.hlc.2022.06.100] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
16
|
Chand S, Wilcox I, McGrady M, Lal S, Hunyor I, O'Sullivan J, Fulthorp E, Price M, Mccoll A. Clinical and Echocardiographic Parameters in Community-Based Individuals Symptomatic Post Pfizer and AstraZeneca COVID-19 Vaccination. Heart Lung Circ 2022. [PMCID: PMC9345547 DOI: 10.1016/j.hlc.2022.06.234] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
17
|
Kopczynska M, Teubner A, Taylor M, Abraham A, Hvas C, Burden S, Carlson G, Lal S. Nutritional autonomy in short bowel syndrome and intestinal fistulas. Clin Nutr ESPEN 2021. [DOI: 10.1016/j.clnesp.2021.09.646] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
18
|
Schneider S, Lal S, Geransar P, Rzepa E, Pironi L, Jeppesen PB. Atlas of variance: awareness of chronic intestinal failure versus chronic kidney failure and key areas for improving care delivery to patients with chronic intestinal failure. Clin Nutr ESPEN 2021. [DOI: 10.1016/j.clnesp.2021.09.383] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
19
|
Allan PJ, Ambrose T, Mountford C, Bond A, Donnellan C, Boyle R, Calvert C, Cernat E, Clarke E, Cooper SC, Donnelly S, Evans B, Glynn M, Hewett R, Holohan AS, Leitch EF, Louis-Auguste J, Mehta S, Naik S, Nightingale J, Rafferty G, Rodrigues A, Sharkey L, Small M, Teubner A, Urs A, Wyer N, Lal S. COVID-19 infection in patients with intestinal failure: UK experience. JPEN J Parenter Enteral Nutr 2021; 45:1369-1375. [PMID: 33586170 PMCID: PMC8013499 DOI: 10.1002/jpen.2087] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2020] [Revised: 02/05/2021] [Accepted: 02/09/2021] [Indexed: 12/24/2022]
Abstract
BACKGROUND The direct effect of the coronavirus disease 2019 (COVID-19) pandemic on patients with intestinal failure (IF) has not been described. METHODS We conducted a nationwide study of UK IF centers to evaluate the infection rates, presentations, and outcomes in patients with types 2 and 3 IF. RESULTS A total of 45 patients with IF contracted COVID-19 between March and August 2020; this included 26 of 2191 (1.2%) home parenteral nutrition (HPN)-dependent adults and 19 of 298 (6.4%) adults hospitalized with type 2 IF. The proportion of patients receiving nursing care for HPN administration was higher in those with community-acquired COVID-19 (66.7%) than the proportion in the entire HPN cohort (26.1%; P < .01). Two HPN-dependent and 1 hospitalized patient with type 2 IF died as a direct consequence of the virus (6.7% of 45 patients with types 2 or 3 infected). CONCLUSION This is the first study to describe the outcomes of COVID-19 in a large cohort of patients requiring long-term PN. Methods to reduce hospital and community nosocomial spread would likely be beneficial.
Collapse
Affiliation(s)
- P J Allan
- Translational Gastroenterology Unit, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
| | - T Ambrose
- Translational Gastroenterology Unit, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
| | - C Mountford
- Department of Gastroenterology, Freeman Hospital, Newcastle, UK
| | - A Bond
- Department of Gastroenterology, Royal Liverpool and Broadgreen Hospitals, Liverpool, UK
| | - C Donnellan
- St James' and Leeds Gastroenterology Institute, St James' Hospital, Leeds, UK
| | - R Boyle
- Department of Biochemistry, Aberdeen Royal Infirmary, Aberdeen, UK
| | - C Calvert
- Department of Gastroenterology, Royal Devon and Exeter Hospital, Exeter, UK
| | - E Cernat
- Department of Paediatric Gastroenterology, Leeds General Infirmary, Leeds, UK
| | - E Clarke
- Department of Gastroenterology, Southampton University Hospital, Southampton, UK
| | - S C Cooper
- GI Medicine, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
| | - S Donnelly
- Leonard Jones' Intestinal Rehabilitation Unit, St Mark's Hospital, Harrow, UK
| | - B Evans
- Department of Gastroenterology, Bristol Royal Infirmary, Bristol, UK
| | - M Glynn
- Centre for Digestive Diseases, Royal London Hospital, London, UK
| | - R Hewett
- Department of Gastroenterology, University of Wales Hospital, Cardiff, UK
| | - A S Holohan
- Nutrition, Leicester Royal Infirmary, Leicester, UK
| | - E F Leitch
- Intestinal Failure Surgery, Glasgow Royal Infirmary, Glasgow, UK
| | | | - S Mehta
- Intestinal Failure Unit, University College London Hospitals, London, UK
| | - S Naik
- Department of Paediatric Gastroenterology, Royal London Children's Hospital, London, UK
| | | | - G Rafferty
- Department of Gastroenterology, Belfast City Hospital, Belfast, UK
| | - A Rodrigues
- Department of Paediatric Gastroenterology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
| | - L Sharkey
- Intestinal Failure and Transplant, Cambridge University Hospitals, Cambridge, UK
| | - M Small
- Leonard Jones' Intestinal Rehabilitation Unit, St Mark's Hospital, Harrow, UK
| | - A Teubner
- Intestinal Failure Unit, Salford Royal Hospital, Salford, UK
| | - A Urs
- Paediatric Gastroenterology, Sheffield Children's Hospital, Sheffield, UK
| | - N Wyer
- Intestinal Failure and Nutrition Support, University Hospitals Coventry and Warwickshire, Coventry, UK
| | - S Lal
- Intestinal Failure Unit, Salford Royal Hospital, Salford, UK.,Division of Diabetes, Endocrinology and Gastroenterology, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and Manchester Academic Health Sciences Centre, Manchester, UK
| |
Collapse
|
20
|
Morris P, Dennis M, Hunyor I, Puranik R, O'Sullivan J, Lal S. Myocardial Fibrosis and Left Ventricular Hypertrophy Elevates Cardiovascular Risk in Patients with Diabetes Mellitus. Heart Lung Circ 2021. [DOI: 10.1016/j.hlc.2021.06.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
21
|
Zaheen M, Wilcox I, Lal S. Are They Durable Enough? Echocardiographic Outcomes of Tissue Aortic Valves and Implications for Future Practice. Heart Lung Circ 2021. [DOI: 10.1016/j.hlc.2021.06.353] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
22
|
Miller B, Green D, Barrett M, Farrer K, Ahmed S, Cloutier A, Teubner A, Abraham A, Lal S. The occurrence of chronic kidney disease in patients on long-term home parenteral nutrition. Clin Nutr ESPEN 2020. [DOI: 10.1016/j.clnesp.2020.09.348] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
23
|
Cloutier A, Deutsch L, Leahy G, Teubner A, Abraham A, Lal S. Outcomes associated with strong opioid use for non-cancer pain in patients with chronic intestinal failure. Clin Nutr ESPEN 2020. [DOI: 10.1016/j.clnesp.2020.09.342] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
24
|
Elfadil O, Velapati S, Hurt R, Lal S, Mundi M. Utility of sub-classification of severe gastrointestinal dysmotility in chronic intestinal failure. Clin Nutr ESPEN 2020. [DOI: 10.1016/j.clnesp.2020.09.373] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
25
|
Rud C, Jørgensen S, Wilkens T, Bager P, Dahlerup J, Tøttrup A, Lal S, Hvas C. Quality of life and wellbeing in patients with an ileostomy: A cross sectional study. Clin Nutr ESPEN 2020. [DOI: 10.1016/j.clnesp.2020.09.324] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
26
|
Eriksen M, Jørgensen S, Lal S, Dahlerup J, Hvas C. Hypophosphataemia and shifts in magnesium and potassium in a specialised intestinal failure unit: an observational cohort study. Clin Nutr ESPEN 2020. [DOI: 10.1016/j.clnesp.2020.09.374] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
27
|
Cloutier A, Deutsch L, Leahy G, Miller B, Teubner A, Abraham A, Pironi L, Lal S. Factors affecting antidepressant use by patients requiring home parenteral nutrition. Clin Nutr ESPEN 2020. [DOI: 10.1016/j.clnesp.2020.09.341] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
28
|
Stanger D, Lal S, Wuppinger T, Hensey M, Ong K, Boone R, Webb J, Grewal J, Moss R. ECHOCARDIOGRAPHIC OUTCOMES FOLLOWING EDWARDS TRANSCATHETER MITRAL VALVE REPLACEMENT SYSTEM FOR SIGNIFICANT MITRAL REGURGITATION: A SINGLE CENTRE EXPERIENCE. Can J Cardiol 2020. [DOI: 10.1016/j.cjca.2020.07.079] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
29
|
Sowerbutts AM, Panter C, Dickie G, Bennett B, Ablett J, Burden S, Lal S. Short bowel syndrome and the impact on patients and their families: a qualitative study. J Hum Nutr Diet 2020; 33:767-774. [DOI: 10.1111/jhn.12803] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2020] [Revised: 06/29/2020] [Accepted: 07/08/2020] [Indexed: 01/02/2023]
Affiliation(s)
- A. M. Sowerbutts
- Faculty of Biology, Medicine and Health and Manchester Academic Health Science Centre University of Manchester Manchester UK
| | | | | | | | - J. Ablett
- St Helen’s and Knowsley NHS Trust Liverpool UK
| | - S. Burden
- Faculty of Biology, Medicine and Health and Manchester Academic Health Science Centre University of Manchester Manchester UK
| | - S. Lal
- Salford Royal NHS Foundation Trust Manchester UK
| |
Collapse
|
30
|
Sowerbutts AM, Lal S, Sremanakova J, Clamp AR, Jayson GC, Hardy L, Sutton E, Raftery AM, Teubner A, Burden S. Dealing with loss: food and eating in women with ovarian cancer on parenteral nutrition. J Hum Nutr Diet 2020; 33:550-556. [PMID: 32026525 DOI: 10.1111/jhn.12738] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
BACKGROUND Malignant bowel obstruction is a common complication of ovarian cancer, resulting in limited oral intake. Home parenteral nutrition (HPN) may be offered to patients in this condition to meet nutritional requirements. However, it is not known how they experience being unable to eat. The present study reports how patients related to food when receiving HPN. METHODS The investigation was a qualitative study underpinned by phenomenology with women with advanced ovarian cancer in bowel obstruction receiving parenteral nutrition. Interview transcripts were analysed thematically guided by the techniques of Van Manen. RESULTS We recruited 20 women to the study. Participants were interviewed a maximum of four times and a total of 39 in-depth longitudinal interviews were conducted. Participants could tolerate minimal amounts of food, if they had a venting gastrostomy. Not being able to eat engendered a sense of sadness and loss, and most women found it challenging to be in the presence of others eating. They adopted strategies to cope, which included fantasising about food and watching cookery programmes. These approaches were not a long-term solution; either participants came to terms with their loss or the strategies became less effective in providing relief. CONCLUSIONS Home parenteral nutrition meets the nutritional requirements of patients with malignant bowel obstruction but cannot replace the non-nutritive functions of food. Healthcare professionals can offer a patient-centred approach by acknowledging the difficulties that patients may face and, wherever possible, encourage them to focus on the positive benefits of interacting with people rather than the loss of eating on social occasions.
Collapse
Affiliation(s)
- A M Sowerbutts
- Faculty of Biology, Medicine and Health and Manchester Academic Health Science Centre, University of Manchester, Manchester, UK
| | - S Lal
- Salford Royal NHS Foundation Trust, Manchester, UK
| | - J Sremanakova
- Faculty of Biology, Medicine and Health and Manchester Academic Health Science Centre, University of Manchester, Manchester, UK
| | - A R Clamp
- Faculty of Biology, Medicine and Health and Manchester Academic Health Science Centre, University of Manchester, Manchester, UK
- The Christie NHS Foundation Trust, Manchester, UK
| | - G C Jayson
- Faculty of Biology, Medicine and Health and Manchester Academic Health Science Centre, University of Manchester, Manchester, UK
- The Christie NHS Foundation Trust, Manchester, UK
| | - L Hardy
- Manchester University NHS Foundation Trust, Manchester, UK
| | - E Sutton
- Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
| | - A-M Raftery
- The Christie NHS Foundation Trust, Manchester, UK
| | - A Teubner
- Salford Royal NHS Foundation Trust, Manchester, UK
| | - S Burden
- Faculty of Biology, Medicine and Health and Manchester Academic Health Science Centre, University of Manchester, Manchester, UK
| |
Collapse
|
31
|
Christodoulidou M, Lal S, Ramachandran N, Burden S, Gibson D, Alnajjar H, Mitra A, Richards T, Muneer A. The use of body composition parameters as predictors of metastatic disease and prognostic indicators in penile cancer – a eUROGEN centre study. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)32759-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
32
|
Bond A, Soop M, Taylor M, Purssell H, Abraham A, Teubner A, Carlson G, Lal S. Home parenteral nutrition and the older adult: Experience from a national intestinal failure unit. Clin Nutr 2020; 39:1418-1422. [DOI: 10.1016/j.clnu.2019.06.019] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2019] [Revised: 06/19/2019] [Accepted: 06/22/2019] [Indexed: 12/18/2022]
|
33
|
Offen S, Simmons L, Lal S, Celermajer D. 301 Characterising the Tricuspid Valve to Inform Interventional Strategies. Heart Lung Circ 2020. [DOI: 10.1016/j.hlc.2020.09.308] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
34
|
Morris P, Lal S, Dennis M, O'Sullivan J, Hunyor I, Grieve S, Bao S, Puranik R. 027 Unexplained Left Ventricular Late Gadolinium Enhancement (LGE) on Cardiac Magnetic Resonance (CMR) Confers an Adverse Prognosis. Heart Lung Circ 2020. [DOI: 10.1016/j.hlc.2020.09.034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
35
|
Jones DJ, Baldwin C, Lal S, Stanmore E, Farrer K, Connolly E, Weekes CE, Anderson L, Murphy J, Gillespie L, Welsh N, Ogden M, McDevitt M, Day R, Lynne S, Paulden P, Gronlund T, Burden ST. Priority setting for adult malnutrition and nutritional screening in healthcare: a James Lind Alliance. J Hum Nutr Diet 2019; 33:274-283. [DOI: 10.1111/jhn.12722] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Affiliation(s)
- D. J. Jones
- Faculty of Biology, Medicine and Health University of Manchester Manchester UK
| | - C. Baldwin
- Department of Nutritional Sciences Kings College London London UK
| | - S. Lal
- Salford Royal Foundation Trust Salford UK
| | - E. Stanmore
- Faculty of Biology, Medicine and Health University of Manchester Manchester UK
| | - K. Farrer
- NHS Salford CCG St James House Salford UK
| | | | - C. E. Weekes
- Guy's & St Thomas' NHS Foundation Trust London UK
| | - L. Anderson
- Buckinghamshire Healthcare NHS Trust Stoke Mandeville Hospital Aylesbury Bucks UK
| | - J. Murphy
- Bournemouth University Bournemouth UK
| | | | - N. Welsh
- Manchester University NHS Foundation Trust Manchester UK
| | - M. Ogden
- Patient and Carer Involvement/Representatives Manchester UK
| | - M. McDevitt
- Patient and Carer Involvement/Representatives Manchester UK
| | - R. Day
- Patient and Carer Involvement/Representatives Manchester UK
| | - S. Lynne
- Patient and Carer Involvement/Representatives Manchester UK
| | - P. Paulden
- Patient and Carer Involvement/Representatives Manchester UK
| | | | - S. T. Burden
- Faculty of Biology, Medicine and Health University of Manchester Manchester UK
| |
Collapse
|
36
|
Abstract
Metabolic bone diseases are a group of conditions that are common complications in patients with intestinal failure. These may occur as a result of the underlying condition, leading to intestinal failure, particularly inflammatory conditions such as Crohn's disease and their associated treatments including corticosteroids. Malabsorption, as a result of a loss of enterocyte mass or gut function, of many nutrients, including vitamin D, may further compound metabolic bone problems, and there has been historical contamination of parenteral nutrition with aluminium that has prevented normal bone metabolism contributing to osteoporosis. This review looks at the diagnosis and current management of bone health in patients with intestinal failure.
Collapse
Affiliation(s)
- P J Allan
- Translational Gastroenterology Unit, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK
| | - S Lal
- Intestinal Failure Unit, Salford Royal NHS Foundation Trust, Salford, UK.,School of medical science, University of Manchester, Manchester, UK
| |
Collapse
|
37
|
Khatib T, Burden S, Lal S, Tyson S. SUN-PO007: Evaluating Long-Term Use of Soybean Oil, Medium-Chain Triglyceride, Olive Oil and Fish Oil (SMOFlipid®) in Adults with Intestinal Failure. Clin Nutr 2019. [DOI: 10.1016/s0261-5614(19)32643-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
38
|
Chadwick P, Abraham A, Ryan K, Teubner A, Bond A, Lal S. SUN-PO262: Sensitivity of Differential Time to Positivity Compared to Pour Plates for Diagnosing Catheter-Related Blood Stream Infection: An Evaluation in Patients with Chronic Intestinal Failure. Clin Nutr 2019. [DOI: 10.1016/s0261-5614(19)32892-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
39
|
Sowerbutts A, Lal S, Sremanakova J, Clamp A, Jayson G, Teubner A, Hardy L, Todd C, Raftery AM, Sutton E, Burden S. SUN-PO078: Home Parenteral Nutrition in Advanced Ovarian Cancer: Making and Implementing the Decision. Clin Nutr 2019. [DOI: 10.1016/s0261-5614(19)32712-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
40
|
Abraham A, Sawbridge D, Cloutier A, Teubner A, Taylor M, Lal S. SUN-PO263: Are Femoral Tunnelled Central Venous Catheters Safe to use for HPN? Clin Nutr 2019. [DOI: 10.1016/s0261-5614(19)32893-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
41
|
Eriksen M, Jorgensen S, Lemming L, Dahlerup J, Lal S, Hvas C. MON-PO351: Patient Characteristics and Clinical Outcomes in a Specialised Intestinal Failure Unit: An Observational Cohort Study. Clin Nutr 2019. [DOI: 10.1016/s0261-5614(19)32186-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
42
|
Soop M, Khan H, Nixon E, Teubner A, Abraham A, Carlson G, Lal S. SUN-PO306: Causes and Outcomes of Intestinal Failure in Crohn’s Disease: An 18-Year Experience from a National Centre. Clin Nutr 2019. [DOI: 10.1016/s0261-5614(19)32936-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
43
|
Bond A, Teubner A, Taylor M, Cawley C, Varden J, Abraham A, Chadwick P, Soop M, Carlson G, Lal S. Catheter-related infections in patients with acute type II intestinal failure admitted to a national centre: Incidence and outcomes. Clin Nutr 2019; 38:1828-1832. [DOI: 10.1016/j.clnu.2018.07.019] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2018] [Accepted: 07/18/2018] [Indexed: 01/09/2023]
|
44
|
Bond A, Teubner A, Taylor M, Willbraham L, Gillespie L, Farrer K, McMahon M, Leahy G, Abraham A, Soop M, Clamp AR, Hasan J, Mitchell C, Jayson GC, Lal S. A novel discharge pathway for patients with advanced cancer requiring home parenteral nutrition. J Hum Nutr Diet 2019; 32:492-500. [PMID: 31006921 DOI: 10.1111/jhn.12650] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
BACKGROUND The use of home parenteral nutrition (HPN) for palliative indications is increasing internationally and is the leading indication in some countries. Discharge on HPN can be complex in metabolically unstable patients and requires intestinal failure expertise. METHODS Between 2012 and 2018, we performed a retrospective analysis aiming to assess the impact of a novel remote discharge pathway for palliative HPN patients. This was evaluated using a quality improvement approach. RESULTS One hundred and twenty-five patients with active malignancy [mean (range) age 58 (25-80) years] were referred to the intestinal failure unit (IFU) for remote discharge. Of 82 patients were discharged from the oncology Centre on HPN using the pathway. The remaining 43 patients either declined HPN or the Oncology team felt that the patient became too unwell for HPN or died prior to discharge. There was an increase in patients referred for remote discharge from 13 in 2012 to 43 in 2017. The mean number of days between receipt of referral by the IFU to discharge on HPN from the oncology centre reduced from 29.4 days to 10.1 days. Following remote discharge, the mean number of days on HPN was 215.9 days. Catheter-related blood stream infection rates in this cohort were very low at 0.169 per 1000 catheter days. CONCLUSIONS This is the first study to demonstrate the remote safe, effective and rapid discharge of patients requiring palliative HPN between two hospital sites. This allows patients with a short prognosis more time in their desired location.
Collapse
Affiliation(s)
- A Bond
- Intestinal Failure Unit, Salford Royal Foundation Trust, Salford, UK
| | - A Teubner
- Intestinal Failure Unit, Salford Royal Foundation Trust, Salford, UK
| | - M Taylor
- Intestinal Failure Unit, Salford Royal Foundation Trust, Salford, UK
| | - L Willbraham
- The Christie NHS Foundation Trust, Manchester, UK
| | - L Gillespie
- The Christie NHS Foundation Trust, Manchester, UK
| | - K Farrer
- Intestinal Failure Unit, Salford Royal Foundation Trust, Salford, UK
| | - M McMahon
- Intestinal Failure Unit, Salford Royal Foundation Trust, Salford, UK
| | - G Leahy
- Intestinal Failure Unit, Salford Royal Foundation Trust, Salford, UK
| | - A Abraham
- Intestinal Failure Unit, Salford Royal Foundation Trust, Salford, UK
| | - M Soop
- Intestinal Failure Unit, Salford Royal Foundation Trust, Salford, UK
| | - A R Clamp
- The Christie NHS Foundation Trust, Manchester, UK
| | - J Hasan
- The Christie NHS Foundation Trust, Manchester, UK
| | - C Mitchell
- The Christie NHS Foundation Trust, Manchester, UK
| | - G C Jayson
- The Christie NHS Foundation Trust, Manchester, UK.,The University of Manchester, Manchester, UK
| | - S Lal
- Intestinal Failure Unit, Salford Royal Foundation Trust, Salford, UK.,The University of Manchester, Manchester, UK
| |
Collapse
|
45
|
Kan Z, Lal S, Ding Y, Lee JE, Lee SH, Lee SK, Yu JH, Choi YL, Kim SW, Nam SJ, Kim JY, Ram S, Powell E, Ching K, Cho SY, Bonato V, Deng S, Park WY, Rejto P, Bienkowska J, Park YH. Abstract PD5-08: Neoadjuvant chemotherapy alters the genomic landscape and immune microenvironment of breast cancers. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-pd5-08] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Understanding how standard-of-care drug treatments affect tumor intrinsic biology and microenvironment is critical for elucidating drug resistance mechanisms and developing better combination therapies as well as new therapies. To characterize the effects of neoadjuvant chemotherapy (NAC) on the genome, transcriptome and tumor infiltrating leukocytes (TILs), we have conducted whole exome and whole transcriptome sequencing of a large longitudinal breast cancer cohort consisting of 146 cases and 281 paired tumor samples. In total, 52 (38%) patients achieved pathologic complete response (pCR) while 85 patients (62%) had residual disease with standard chemotherapy regimen. Tumor biopsies were collected for each patient at three time points – pre-treatment, three weeks after the first cycle of anthracycline and cyclophosphamide (AC) and at the time of surgery after 3 more cycles of AC followed by 4 cycles of taxane or taxane plus Herceptin in case of HER2+ subtype. We detected 5,955 protein-altering somatic mutations affecting 4,414 genes in pretreatment samples and 502 acquired mutations in surgery samples affecting 477 genes including 19recurrently mutated genes such as TP53 and NOTCH1. Across all subtypes, 4,346 genes were differentially expressed (DE) following NAC treatment and significantly enriched in pathways such as cell cycle, ER signaling, PI3K/mTOR, immune and metabolism. Expression-based virtual microdissection analysis indicated that NAC treatment induced an increase in the fractions of stromal and adjacent normal tissue compartment, consistent with observed reduction in tumor cellularity. To assess the NAC induced changes in the molecular landscape of these tumors, we compared molecular features including gene expression signatures, mutation prevalence and copy number alteration between three time points while adjusting for confounding effects of molecular subtype and tumor cellularity. We found that NAC induced dynamic changes in gene expression signatures associated with proliferation and immunomodulatory treatment response. We further validated the observed pattern of change in TILs through histopathology and digital imaging analyses. In pretreatment tumors, 116 genes were DE between patients with pCR vs. those with residual disease with significant enrichment in immune/inflammatory pathways. Further, pre-treatment TIL levels were found to be significantly associated with pCR, echoing previous reports in breast cancers that implicated anti-tumor immunity in mediating the efficacy of chemotherapies. Our analyses also revealed associations between NAC response and baseline genomic attributes such as genomic alterations that affect DNA damage repair pathways. Taken together, these results suggest that NAC induced a multitude of changes on the genomic landscape and immune microenvironment of breast cancers, some of which point to combination strategies with immunomodulatory therapies and therapies that target DNA damage repair.
Citation Format: Kan Z, Lal S, Ding Y, Lee JE, Lee S-H, Lee SK, Yu JH, Choi Y-l, Kim SW, Nam SJ, Kim J-Y, Ram S, Powell E, Ching K, Cho SY, Bonato V, Deng S, Park W-Y, Rejto P, Bienkowska J, Park Y-H. Neoadjuvant chemotherapy alters the genomic landscape and immune microenvironment of breast cancers [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr PD5-08.
Collapse
Affiliation(s)
- Z Kan
- Pfizer, San Diego, CA; Samsung Medical Center, Seoul, Korea
| | - S Lal
- Pfizer, San Diego, CA; Samsung Medical Center, Seoul, Korea
| | - Y Ding
- Pfizer, San Diego, CA; Samsung Medical Center, Seoul, Korea
| | - JE Lee
- Pfizer, San Diego, CA; Samsung Medical Center, Seoul, Korea
| | - S-H Lee
- Pfizer, San Diego, CA; Samsung Medical Center, Seoul, Korea
| | - SK Lee
- Pfizer, San Diego, CA; Samsung Medical Center, Seoul, Korea
| | - JH Yu
- Pfizer, San Diego, CA; Samsung Medical Center, Seoul, Korea
| | - Y-l Choi
- Pfizer, San Diego, CA; Samsung Medical Center, Seoul, Korea
| | - SW Kim
- Pfizer, San Diego, CA; Samsung Medical Center, Seoul, Korea
| | - SJ Nam
- Pfizer, San Diego, CA; Samsung Medical Center, Seoul, Korea
| | - J-Y Kim
- Pfizer, San Diego, CA; Samsung Medical Center, Seoul, Korea
| | - S Ram
- Pfizer, San Diego, CA; Samsung Medical Center, Seoul, Korea
| | - E Powell
- Pfizer, San Diego, CA; Samsung Medical Center, Seoul, Korea
| | - K Ching
- Pfizer, San Diego, CA; Samsung Medical Center, Seoul, Korea
| | - SY Cho
- Pfizer, San Diego, CA; Samsung Medical Center, Seoul, Korea
| | - V Bonato
- Pfizer, San Diego, CA; Samsung Medical Center, Seoul, Korea
| | - S Deng
- Pfizer, San Diego, CA; Samsung Medical Center, Seoul, Korea
| | - W-Y Park
- Pfizer, San Diego, CA; Samsung Medical Center, Seoul, Korea
| | - P Rejto
- Pfizer, San Diego, CA; Samsung Medical Center, Seoul, Korea
| | - J Bienkowska
- Pfizer, San Diego, CA; Samsung Medical Center, Seoul, Korea
| | - Y-H Park
- Pfizer, San Diego, CA; Samsung Medical Center, Seoul, Korea
| |
Collapse
|
46
|
Bond A, Purssell H, Taylor M, Teubner A, Abraham A, Soop M, Carlson G, Lal S. Home parenteral nutrition in the elderly: experience from a national intestinal failure centre. Clin Nutr ESPEN 2019. [DOI: 10.1016/j.clnesp.2018.12.052] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
47
|
Bond A, Teubner A, Taylor M, Willbraham L, Gillespie L, Farrer K, Leahy G, Abraham A, Clamp A, Jayson G, Lal S. A novel discharge pathway for patients requiring palliative home parenteral nutrition. Clin Nutr ESPEN 2019. [DOI: 10.1016/j.clnesp.2018.12.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
48
|
Wang N, Fulcher J, Abeysuriya N, Kumar S, Wilcox I, Rodgers A, Lal S. More Intensive LDL-C Lowering Reduces Major Vascular Events Beyond Current Recommendations: Systematic Review and Meta-Analysis. Heart Lung Circ 2019. [DOI: 10.1016/j.hlc.2019.06.044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
49
|
Twist K, Ablett J, Wearden A, Paine P, Vasant D, Lal S, Peters S. “An orchestra without a conductor”: A qualitative exploration of the journey from symptom onset to diagnosis in patients with severe gastrointestinal dysmotility. Clin Nutr ESPEN 2018. [DOI: 10.1016/j.clnesp.2018.09.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
50
|
Ablett J, Vasant D, Taylor M, Cawley C, Lal S. Social support and employment status are associated with negative affect in patients with type 3 intestinal failure. Clin Nutr ESPEN 2018. [DOI: 10.1016/j.clnesp.2018.09.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|